The category of MDS with defining genetic abnormalities includes the following entities: MDS with biallelic TP53 inactivation, MDS with low blasts and SF3B1 mutation (MDS-SF3B1), and MDS with low blasts and del(5q) [117]. This evidence concerns the gene TP53 and myelodysplastic syndrome.